CTMS cloud application streamlines trial management and delivers end-to-end visibility of clinical trials on one platform
Allergan Granted Marketing Authorization by the FDA for TrueTear™, the First Intranasal Neurostimulating Device Proven to Temporarily Increase Tear Production
AXIM Biotech Retains Ora to Manage Upcoming Product Development and Clinical Trials on Glaucoma and Dry Eye Indications
Novaliq Announces Last Patient Enrolled in Phase 2 Clinical Trial of CyclASol® for the Treatment of Moderate to Severe Dry Eye Disease
Dr. Hollander joins Ora after 10 years as industry leader at Allergan.
Meet Ora’s New Chief Medical Officer at ARVO
Ora, ophthalmic leader, deepens European foothold as part of Global expansion